Study: New biopsy methods can help improve benefit-harm ratio of PSA screening
The benefit of population-based PSA screening for men with an average risk of prostate cancer does not outweigh the harm caused.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario